Elizabeth Gizewski

665 total citations
20 papers, 567 citations indexed

About

Elizabeth Gizewski is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Elizabeth Gizewski has authored 20 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 15 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Elizabeth Gizewski's work include Adenosine and Purinergic Signaling (19 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (10 papers). Elizabeth Gizewski is often cited by papers focused on Adenosine and Purinergic Signaling (19 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (10 papers). Elizabeth Gizewski collaborates with scholars based in United States, Belarus and Belgium. Elizabeth Gizewski's co-authors include John A. Auchampach, Tina C. Wan, Kenneth A. Jacobson, Dilip K. Tosh, Zhan‐Guo Gao, Laura M. Kreckler, Daniela Salvemini, Silvia Paoletta, Dharini van der Hoeven and Steven M. Moss and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Elizabeth Gizewski

20 papers receiving 556 citations

Peers

Elizabeth Gizewski
Lauren J. Murphree United States
Xiao-duo Ji United States
Sabine Meis Germany
Heidi Taylor United States
Gordan Kilic United States
U. Braam Germany
Jill Coates United Kingdom
Elizabeth Gizewski
Citations per year, relative to Elizabeth Gizewski Elizabeth Gizewski (= 1×) peers Daniela Tuscano

Countries citing papers authored by Elizabeth Gizewski

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Gizewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Gizewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Gizewski more than expected).

Fields of papers citing papers by Elizabeth Gizewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Gizewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Gizewski. The network helps show where Elizabeth Gizewski may publish in the future.

Co-authorship network of co-authors of Elizabeth Gizewski

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Gizewski. A scholar is included among the top collaborators of Elizabeth Gizewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Gizewski. Elizabeth Gizewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tosh, Dilip K., Antonella Ciancetta, Philip Z. Mannes, et al.. (2018). Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega. 3(10). 12658–12678. 11 indexed citations
2.
Du, Lili, Zhan-Guo Gao, Silvia Paoletta, et al.. (2017). Species differences and mechanism of action of A3 adenosine receptor allosteric modulators. Purinergic Signalling. 14(1). 59–71. 16 indexed citations
3.
Tosh, Dilip K., Aaron Janowsky, Amy J. Eshleman, et al.. (2017). Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters. Journal of Medicinal Chemistry. 60(7). 3109–3123. 15 indexed citations
4.
Ciancetta, Antonella, Philip Z. Mannes, Jinha Yu, et al.. (2017). Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners. MedChemComm. 8(8). 1659–1667. 14 indexed citations
5.
Carlin, Jesse L., Shalini Jain, Elizabeth Gizewski, et al.. (2016). Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms. Neuropharmacology. 114. 101–113. 56 indexed citations
6.
Tosh, Dilip K., Antonella Ciancetta, Robert O’Connor, et al.. (2016). Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A3Adenosine Receptor Agonists. Journal of Medicinal Chemistry. 59(7). 3249–3263. 10 indexed citations
7.
Tosh, Dilip K., Zhoumou Chen, Silvia Paoletta, et al.. (2015). Rigidified A3Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy. ACS Medicinal Chemistry Letters. 6(7). 804–808. 19 indexed citations
8.
Tosh, Dilip K., Silvia Paoletta, Zhoumou Chen, et al.. (2015). Structure-based design, synthesis by click chemistry and in vivo activity of highly selective A3 adenosine receptor agonists. MedChemComm. 6(4). 555–563. 16 indexed citations
9.
Tosh, Dilip K., Silvia Paoletta, Steven M. Moss, et al.. (2014). In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A3 Adenosine Receptor Agonists. Journal of Medicinal Chemistry. 57(23). 9901–9914. 48 indexed citations
10.
Kozma, Eszter, Elizabeth Gizewski, Dilip K. Tosh, et al.. (2013). Characterization by flow cytometry of fluorescent, selective agonist probes of the A3 adenosine receptor. Biochemical Pharmacology. 85(8). 1171–1181. 15 indexed citations
11.
Chandrasekera, P. Charukeshi, Tina C. Wan, Elizabeth Gizewski, John A. Auchampach, & Robert D. Lasley. (2013). Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling. Cellular Signalling. 25(4). 736–742. 31 indexed citations
12.
Paoletta, Silvia, Dilip K. Tosh, Elizabeth Gizewski, et al.. (2013). Rational Design of Sulfonated A3 Adenosine Receptor-Selective Nucleosides as Pharmacological Tools To Study Chronic Neuropathic Pain. Journal of Medicinal Chemistry. 56(14). 5949–5963. 39 indexed citations
13.
Tosh, Dilip K., Francesca Deflorian, Khai Phan, et al.. (2012). Structure-Guided Design of A3Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions. Journal of Medicinal Chemistry. 55(10). 4847–4860. 74 indexed citations
14.
Wan, Tina C., Dilip K. Tosh, Lili Du, et al.. (2011). Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts. BMC Pharmacology. 11(1). 11–11. 20 indexed citations
15.
Hoeven, Dharini van der, Tina C. Wan, Elizabeth Gizewski, et al.. (2011). A Role for the Low-Affinity A2B Adenosine Receptor in Regulating Superoxide Generation by Murine Neutrophils. Journal of Pharmacology and Experimental Therapeutics. 338(3). 1004–1012. 44 indexed citations
16.
Hoeven, Dharini van der, Elizabeth Gizewski, & John A. Auchampach. (2010). Activation of the A3 adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils. Biochemical Pharmacology. 79(11). 1667–1673. 9 indexed citations
17.
Auchampach, John A., Elizabeth Gizewski, Tina C. Wan, et al.. (2009). Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor. Biochemical Pharmacology. 79(7). 967–973. 21 indexed citations
18.
Auchampach, John A., Laura M. Kreckler, Tina C. Wan, et al.. (2009). Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog. Journal of Pharmacology and Experimental Therapeutics. 329(1). 2–13. 32 indexed citations
19.
Kreckler, Laura M., Elizabeth Gizewski, Tina C. Wan, & John A. Auchampach. (2009). Adenosine Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Murine Macrophages through a Protein Kinase A- and Exchange Protein Activated by cAMP-Independent Signaling Pathway. Journal of Pharmacology and Experimental Therapeutics. 331(3). 1051–1061. 38 indexed citations
20.
Melman, Artem, Zhan‐Guo Gao, Tina C. Wan, et al.. (2008). Design of (N)-methanocarba adenosine 5′-uronamides as species-independent A3 receptor-selective agonists. Bioorganic & Medicinal Chemistry Letters. 18(9). 2813–2819. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026